Heart failure (HF) is the most rapidly growing cardiovascular health burden worldwide. HF
can be classified into three groups based on the percentage of the ejection fraction (EF) …

The endothelium can evoke relaxations of the underlying vascular smooth muscle, by
releasing vasodilator substances. The best‐characterized endothelium‐derived relaxing …

The role of body composition in patients with heart failure (HF) has been receiving much
attention in the last few years. Particularly, reduced lean mass (LM), the best surrogate for …

Lipoic acid (LA) is an antioxidant able to produce its effects in aqueous or lipophilic
environments. Lipoate is the conjugate base of lipoic acid, and the most prevalent form of LA …

Chronic heart failure (CHF) impairs critical structural and functional components of the O2
transport pathway resulting in exercise intolerance and, consequently, reduced quality of …

Diabetes mellitus increases the risk of developing heart failure, and the co-existence of both
diseases worsens cardiovascular outcomes, hospitalization, and the progression of heart …

As dysfunction of the vascular system is an early, modifiable step in the progression of many
cardiovascular diseases, there is demand for methods to monitor the health of the vascular …

Objective While vascular dysfunction is well defined in patients with heart failure (HF) with
reduced ejection fraction (HFrEF), disease-related alterations in the peripheral vasculature …

Chronic obstructive pulmonary disease (COPD) is characterized by low pulmonary function,
inflammation, free radical production, vascular dysfunction, and subsequently a greater …

Objectives: Using flow-mediated vasodilation (FMD) and reactive hyperemia (RH), this study
aimed to provide greater insight into left ventricular assist device (LVAD)–induced changes …